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Phebestin, a NewInhibitor of Aminopeptidase N, Produced by Streptomyces sp. MJ716-m3
MACHIKO NaGAI1", FUKIKO KOJIMAf, HlROSHI NaGANAWA1", MASA HAMADA1, Takaaki AoYAGit tf and Tomio Takeuchi1 1 Institute of Microbial Chemistry, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan n Showa College of Pharmaceutical Sciences, Tokyo 194, Japan (Received for publication July 2, 1996) Aminopeptidase N [AP-N, EC 3.4.ll.2] is a Zn2+-dependent ectoenzyme that is anchored in the plasma membranevia a hydrophobic domain adjacent to a small cytoplasmic region at the NH2terminus1'2). This enzyme is widely expressed by the brush border of the small intestine, synaptic cells of the central nervous system, and hematopoietic cells of myeloid lineage3). It has been postulated that AP-N performs multiple functions to regulate the action of hormonesand neurotransmitters by inactivating such peptides at the cell surface4' 5).
Recently, this enzyme has been proved to be identical to the humanmyeloid plasma membraneglycoprotein CD13 which is expressed on human normal and malignant hematopoietic cells, and humanmalignant melanoma cells, but not normal melanocytes6'7). It has been indicated that AP-N is involved in the process to degrade and invade the extracellular matrix by tumor cells7~9). Furthermore, it has been demonstrated that the inhibition of AP-N by enzyme inhibitors or antibodies against AP-N is correlated with growth suppression of humantumor cells10). Thus, it is expected that the specific AP-Ninhibitor may become a drug to suppress the metastasis or growth of certain cancers.
We have already reported actinonin11^probestin12) and leuhistin13) as specific inhibitors of AP-N. We continued the screening for new AP-Ninhibitors and discovered phebestin ( Fig. 1 ) from the culture of Streptomyces sp. MJ716-m3. In this communication, we report the production, isolation, physico-chemical properties, structure determination and biological activities of the inhibitor. The strain MJ716-m3 was inoculated into 110ml of a production mediumconsisting of Bacto Soytone 1.0%, galactose 2.0%, corn steep liquor 0.5%, dextrin 2.0%, glycerol 1.0%, (NH4)2SO4 0.2% and CaCO3 0.2% (pH 7.4 before sterilization) in a 500-ml Erlenmeyer flask, and cultured at 27°C for 3 days on a rotary shaker (180rpm) to obtain a seed culture. Twoml of this seed culture were inoculated into 110ml of the same mediumin a 500-ml Erlenmeyer flask and cultured for 3 days under the same conditions. JAN. 1997 The isolation of phebestin was followed by measuring the inhibitory activity against AP-N from hog kidney (purchased from Boehringer Mannheim GmbH, FRG) as reported previously1 1}. The culture filtrate (9.8 liters) was passed through a column of Diaion HP-20 (1 liter), which was washed with water and eluted with 50% aqueous acetone. The active fractions were concentrated under reduced pressure to remove acetone. The resulting solution was adjusted to pH 2.0 with HC1, and then extracted with equal volume of BuOH. The BuOHlayer HPLC, performed by a Gilson's system equipped with a Waters 991J photodiode array detector. It was applied to a reversed phase HPLCcolumn; Shiseido GAPCELL PAKC18 SG120 20 x250mm which was equilibrated with a solvent mixture ofMeCN-0.1% TFA (6 : 19) and a flow rate of 8 ml/minute, and was eluted with the same solvent. The active fractions were concentrated and lyophilized to give a slightly yellow powder. This powder was dissolved in MeOH, and chromatographed on a column of Sephadex LH20 (1.5 x91cm) with MeOH.
The active fractions were concentrated under reduced pressure to give phebestin as a colorless powder (15.6 mg).
The physico-chemical properties of phebestin are summarized in Table 1 On ODS silica gel TLC plate (Merck, Art No. 15389) with CH3CN-buffered solution of 5% CH3COOK and 1% citric acid monohydrate (7 : 13).
mumat 259 (e 441). The IR spectrum suggested the presence of a peptide bond (1670 and 1520cm"1). The molecular formula of phebestin was established as C24H31N3O5 by FAB-MS and elemental analysis. The amino acid analysis of the acid hydrolysate of phebestin suggested the amino acid constitution was Val (1), Phe
(1), f/zretf-3-amino-2-hydroxy-phenylbutanoic acid (AHPA, 1)14' 15). The XH and 13C NMR data on phebestin are shown in Table 2 . The assignments of proton and carbon signals were determined by the 1H-1H COSY, HMBC,HSQCand DEPT experiments. These data were consistent with the aminoacid residues which were detected by the amino acid analysis. The configuration of the each amino acid residue was examined by the procedure described by Nishikiori et Consequently, the structure of phebestin was determined
The inhibitory activities of phebestin and various inhibitors of aminopeptidases are shown in Table 3 .
Phebestin inhibits not only AP-N but also AP-A and AP-B. It is competitive with the substrate L-leucine-j8- naphthylamide. The Ki value of phebestin was 2.95 x 10~8 m. It has no antimicrobial activity at 100/jg/ml. It has low toxicity; there were no deaths after intraperitoneal injection of mice with lOOmg/kg of phebestin. 
